Innovaare Compliance

JANUARY 15, 2024

The Prescription Drug Program, commonly known as Medicare Part D, is undergoing significant transformations in 2025 due to the Inflation Reduction Act (IRA) of 2022. Medicare Part D will have three (3) phases instead of four (4) – Deductible, Initial Coverage Phase and Catastrophic Phase. generics) in the catastrophic phase.

Medicare 52

Medicare Medicare Compliance FDA 52

Health Care Law Brief

FEBRUARY 8, 2024

The HMH Bill would allow Article 28 general hospitals to provide home health care services without an Article 36 license, provided that a majority of the hospital’s patient care hours are conducted within the hospital and the patient has a preexisting clinical relationship with the general hospital. If approved, the budget also includes $120.4

Medicaid 52

Medicaid Medicaid Nurses Licensing 52

Hall Render

MAY 10, 2024

Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ million expansion ‘Very, very unusual.’

Nursing Homes 40

Nursing Homes Nurses Hospitals Medicaid 40

Hall Render

DECEMBER 1, 2023

to Recruit, Train Primary Care Students UAMS Gets $17.5M to Recruit, Train Primary Care Students UAMS Gets $17.5M to hospitals Propella Therapeutics, Pittsboro firm with 5 employees, sold for $175M Winston-Salem’s clinical research organization Javara raises $9.43

Nursing Homes 40

Nursing Homes Nurses COVID-19 Ransomware 40

Healthcare Law Blog

NOVEMBER 13, 2023

On November 6, 2023, the Centers for Medicare and Medicaid Services (“CMS”) released the contract year 2025 proposed rule for Medicare Advantage (“MA”) organizations and Part D sponsors (the “Proposed Rule”). The UM committee was established in April 2023 in the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F).

Medicare 59

Medicare Medicare Medicaid Medicaid 59

Healthcare Law Blog

AUGUST 25, 2022

The expansive legislation includes key health care provisions, including drug pricing reforms, inflationary rebates, Medicare Part D benefit redesign, as well as myriad other updates. Medicare Drug Price Negotiation Program. The drug publication date for 2026 will be chosen by September 1, 2023.

Medicare 52

Medicare Medicare Medicaid Medicaid 52

Health Law Advisor

SEPTEMBER 1, 2023

On August 29, 2023, the Centers for Medicare & Medicaid Services (CMS) announced the ten (10) Medicare Part D drugs selected for the first round of negotiations of the Medicare Drug Price Negotiation Program (Program)—a few days before the September 1, 2023, statutory deadline imposed by the Inflation Reduction Act (IRA).

Medicare 69

Medicare Medicare Licensing Medicaid 69